Skip to main content
. Author manuscript; available in PMC: 2014 Nov 27.
Published in final edited form as: J Med Chem. 2013 Aug 14;56(22):8972–8983. doi: 10.1021/jm4007752

Figure 4.

Figure 4

Representative SAH-like, mechanism-based and carbamate-containing inhibitors of DOT1L. (Ki or IC50 values are from original references. IC50 values may not be used directly to compare the relative inhibitory potency, due to possibly different assay conditions.)